Open house Rituximab discount agreements
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume commitment; participation does not guarantee any sales or revenue.
Agreements may be superseded by a nationwide or region-wide competitive discount contract for the same active substance...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Nov 2026
- Supply of pharmaceutical products containing Rituximab (ATC L01FA01) to AOK Bayern
- Non-exclusive discount agreements under §130a Abs. 8 SGB V
Show full summary
Open-house model for non-exclusive discount agreements for the active substance Rituximab (ATC L01FA01) with AOK Bayern. This is not a public procurement procedure but a voluntary agreement under §130a Abs. 8 SGB V. All interested pharmaceutical companies meeting eligibility can join. No estimated value or award criteria provided as all eligible participants are accepted. Contract duration from 01.12.2024 to 30.11.2026, with possible earlier termination if a competing nationwide discount agreement takes effect.
Risks
No estimated value or volume commitment; participation does not guarantee any sales or revenue.
Agreements may be superseded by a nationwide or region-wide competitive discount contract for the same active substance...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company (pharmazeutischer Unternehmer)
- Provide signed contract and annex defining covered medicines
Administrative
- Submit signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Rituximab discount agreements
Open-house model for non-exclusive discount agreements for Rituximab. The AOK Bayern offers identical, non-negotiable contracts to all interested pharmaceutical companies that meet the eligibility criteria.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Oct 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 627573-2024
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume commitment; participation does not guarantee any sales or revenue.
Agreements may be superseded by a nationwide or region-wide competitive discount contract for the same active substance...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications